Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Labopharm and Sepracor to develop new dosage forms of levalbuterol

June 20, 1997

PPL Therapeutics authorized to start phase II trials with transgenic product

June 18, 1997

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

New asthma treatment now available in Canada

June 17, 1997

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

June 17, 1997

IND for gene therapy for cystic fibrosis approved

June 13, 1997

NIH funds high-throughput screening in allergic inflammation and immunology by Cadus

June 11, 1997

Inflazyme granted Australian patent for antiinflammatory agents

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

Clinical trials for Albuterol Spiros completed

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.